SV2, a Brain Synaptic Vesicle Protein Homologous to Bacterial Transporters
The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
Synaptic vesicle protein 2 (SV2) is a membrane glycoprotein specifically localized to secretory vesicles in neurons and endocrine cells. As a first step toward understanding the function of SV2 in neural secretion, a rat brain complementary DNA (cDNA) that encodes SV2 was isolated and characterized. Analyses of this cDNA predict that SV2 contains 12 transmembrane domains. The NH 2 -terminal half of the protein shows significant amino acid sequence identity to a family of bacterial proteins that transport sugars, citrate, and drugs. Expression of the SV2 cDNA in COS cells yielded a high level of SV2-like immunoreactivity distributed in a reticular and punctate pattern, which suggests localization to intracellular membranes. Its localization to vesicles, predicted membrane topology, and sequence identity to known transporters suggest that SV2 is a synaptic vesicle-specific transporter.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The pre-synaptic vesicle protein 2 (SV2) is a glycoprotein [43] present within the membrane (with 12 transmembrane domains) of every secretory vesicle, including synaptic vesicles”
From Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression (2025) · cites this paper as [43]
Citations
Cites
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
The scanning model for translation: an update.
Kozak, M. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.2.229 · Cited by 3,486
Syntaxin: A Synaptic Protein Implicated in Docking of Synaptic Vesicles at Presynaptic Active Zones
Bennett, M. K., Calakos, N., & Scheller, R. H. (1992) · Science · doi:10.1126/science.1321498 · Cited by 1,263
Self-citationCloning and Expression of a Rat Brain GABA Transporter
Guastella, J., Nelson, N., Nelson, H., Czyzyk, L., Keynan, S., Miedel, M. C., Davidson, N., Lester, H. A., & Kanner, B. I. (1990) · Science · doi:10.1126/science.1975955 · Cited by 879
Cystic fibrosis: molecular biology and therapeutic implications
Collins, F. (1992) · Science · doi:10.1126/science.1375392 · Cited by 822
Buckley, K., & Kelly, R. B. (1985) · The Journal of cell biology · doi:10.1083/jcb.100.4.1284 · Cited by 712
Cloning and Expression of a Cocaine-Sensitive Rat Dopamine Transporter
Kilty, J. E., Lorang, D., & Amara, S. G. (1991) · Science · doi:10.1126/science.1948035 · Cited by 594
Proteins of synaptic vesicles involved in exocytosis and membrane recycling
Südhof, T. C., & Jahn, R. (1991) · Neuron · doi:10.1016/0896-6273(91)90165-v · Cited by 521
Mammalian and bacterial sugar transport proteins are homologous
Maiden, M. C. J., Davis, E. O., Baldwin, S. A., Moore, D. C. M., & Henderson, P. J. F. (1987) · Nature · doi:10.1038/325641a0 · Cited by 398
Cited by
Pao, S. S., Paulsen, I. T., & Saier, M. H. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.1.1-34.1998 · Cited by 2,297
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
Lynch, B. A., Lambeng, N., Nocka, K., Kensel-Hammes, P., Bajjalieh, S. M., Matagne, A., & Fuks, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308208101 · Cited by 1,610
Self-citationThe molecular machinery for secretion is conserved from yeast to neurons.
Bennett, M. K., & Scheller, R. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2559 · Cited by 650
Self-citationDifferential expression of synaptic vesicle protein 2 (SV2) isoforms
Bajjalieh, S., Frantz, G., Weimann, J., McConnell, S., & Scheller, R. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-09-05223.1994 · Cited by 440
Self-citationEdelmann, L., Hanson, P. I., Chapman, E. R., & Jahn, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb06995.x · Cited by 452
Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
Crowder, K. M., Gunther, J. M., Jones, T. A., Hale, B. D., Zhang, H. Z., Peterson, M. R., Scheller, R. H., Chavkin, C., & Bajjalieh, S. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15268 · Cited by 415
Self-citationSynaptic Vesicles and Exocytosis
Jahn, R., & Sudhof, T. C. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.001251 · Cited by 383
SV2A and SV2B Function as Redundant Ca2+ Regulators in Neurotransmitter Release
Janz, R., Goda, Y., Geppert, M., Missler, M., & Südhof, T. C. (1999) · Neuron · doi:10.1016/s0896-6273(00)81046-6 · Cited by 367
Craig, A. M., Blackstone, C. D., Huganir, R. L., & Banker, G. (1993) · Neuron · doi:10.1016/0896-6273(93)90054-u · Cited by 336
Nabulsi, N. B., Mercier, J., Holden, D., Carré, S., Najafzadeh, S., Vandergeten, M.-C., Lin, S.-F., Deo, A., Price, N., Wood, M., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.168179 · Cited by 296
“The synaptic vesicle glycoprotein 2A (SV2A) is a transmembrane protein expressed ubiquitously in secretory vesicles in all brain areas (1,2).”
BackgroundStorage and release of neurotransmitters
Kelly, R. B. (1993) · Cell · doi:10.1016/s0092-8674(05)80027-3 · Cited by 322
Visualization of the Dynamics of Synaptic Vesicle and Plasma Membrane Proteins in Living Axons
Nakata, T., Terada, S., & Hirokawa, N. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.3.659 · Cited by 314
THE ROLE OF VESICULAR TRANSPORT PROTEINS IN SYNAPTIC TRANSMISSION AND NEURAL DEGENERATION
Liu, Y., & Edwards, R. H. (1997) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.20.1.125 · Cited by 296
Keratan sulfate, a complex glycosaminoglycan with unique functional capability
Caterson, B., & Melrose, J. (2018) · Glycobiology · doi:10.1093/glycob/cwy003 · Cited by 249
Gillard, M., Fuks, B., Leclercq, K., & Matagne, A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.04.064 · Cited by 253
Lopez-Nieto, C. E., You, G., Bush, K. T., Barros, E. J. G., Beier, D. R., & Nigam, S. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6471 · Cited by 252
The major facilitator superfamily.
Saier, M. H., Beatty, J. T., Goffeau, A., Harley, K. T., Heijne, W. H., Sc, H., Jack, D. L., Jähn, P. S., Lew, K., Liu, J., et al. (1999) · PubMed · Cited by 256
Glycosylated SV2A and SV2B Mediate the Entry of Botulinum Neurotoxin E into Neurons
Dong, M., Liu, H., Tepp, W. H., Johnson, E. A., Janz, R., & Chapman, E. R. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-07-0765 · Cited by 230
SNAREs and SNARE regulators in membrane fusion and exocytosis
Gerst, J. E. (1999) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s000180050328 · Cited by 227
SV2 modulates the size of the readily releasable pool of secretory vesicles
Xu, T., & Bajjalieh, S. M. (2001) · Nature Cell Biology · doi:10.1038/35087000 · Cited by 212
Self-citationJanz, R., & Südhof, T. C. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00370-x · Cited by 213
Cell entry strategy of clostridial neurotoxins
Binz, T., & Rummel, A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06093.x · Cited by 207
Acetylcholine Transport, Storage, And Release
Parsons, S. M., Prior, C., & Marshall, I. G. (1993) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60572-3 · Cited by 206
Brain contains two forms of synaptic vesicle protein 2.
Bajjalieh, S. M., Peterson, K., Linial, M., & Scheller, R. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2150 · Cited by 197
Self-citationSynaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond
Löscher, W., Gillard, M., Sands, Z. A., Kaminski, R. M., & Klitgaard, H. (2016) · CNS Drugs · doi:10.1007/s40263-016-0384-x · Cited by 184
“The latter is supported by homology with the major facilitator superfamily (MFS) of membrane transport proteins [32] and by the suggestion that SV2A is a galactose transporter [33].”
BackgroundMolecular cloning of a putative vesicular transporter for acetylcholine.
Roghani, A., Feldman, J., Kohan, S. A., Shirzadi, A., Gundersen, C. B., Brecha, N., & Edwards, R. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10620 · Cited by 180
SV2 Renders Primed Synaptic Vesicles Competent for Ca2+-Induced Exocytosis
Chang, W.-P., & Südhof, T. C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4521-08.2009 · Cited by 176
“…et al., 2004), the transmembrane sequences were hypothesized to function as transporters due to their homology to sugar transporter proteins (Bajjalieh et al., 1992; Feany et al., 1992; Gingrich et al., 1992; Bajjalieh et al., 1993; Janz and Südhof, 1999), and the glycosylated…”
BackgroundInfluentialDal Bo, G., St‐Gelais, F., Danik, M., Williams, S., Cotton, M., & Trudeau, L. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02277.x · Cited by 159
The 12-transmembrane helix transporters
Henderson, P. J. F. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90144-f · Cited by 157
Molecular biology of the vesicular ACh transporter.
Usdin, T., Eiden, L., Bonner, T., & Erickson, J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93906-e · Cited by 144
Molecular Cloning and Characterization of Human Keratan Sulfate Gal-6-Sulfotransferase
Fukuta, M., Inazawa, J., Torii, T., Tsuzuki, K., Shimada, E., & Habuchi, O. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32321 · Cited by 151
Gillard, M., Chatelain, P., & Fuks, B. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.02.022 · Cited by 148
Mundigl, O., Matteoli, M., DANIELL, L. W., Reetz, A., Metcalf, A. B., Jahn, R., & Camilli, P. V. D. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.6.1207 · Cited by 161
Schivell, A. E., Batchelor, R., & Bajjalieh, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27770 · Cited by 145
Self-citationSV2 Mediates Entry of Tetanus Neurotoxin into Central Neurons
Yeh, F. L., Dong, M., Yao, J., Tepp, W. H., Lin, G., Johnson, E. A., & Chapman, E. R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001207 · Cited by 145
SV2 regulates neurotransmitter release via multiple mechanisms
Nowack, A., Yao, J., Custer, K. L., & Bajjalieh, S. M. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00259.2010 · Cited by 138
Self-citationPermeation Properties of Neurotransmitter Transporters
Lester, H. A., Mager, S., Quick, M. W., & Corey, J. L. (1994) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.34.040194.001251 · Cited by 148
Identification and characterization of Drosophila genes for synaptic vesicle proteins
DiAntonio, A., Burgess, R. W., Chin, A., Deitcher, D. L., Scheller, R. H., & Schwarz, T. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-11-04924.1993 · Cited by 140
Self-citationDouble Receptor Anchorage of Botulinum Neurotoxins Accounts for their Exquisite Neurospecificity
Rummel, A. (2012) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-33570-9_4 · Cited by 142
Levetiracetam Mechanisms of Action: From Molecules to Systems
Contreras-García, I. J., Cárdenas-Rodríguez, N., Romo-Mancillas, A., Bandala, C., Zamudio, S. R., Gómez-Manzo, S., Hernández-Ochoa, B., Mendoza-Torreblanca, J. G., & Pichardo-Macías, L. A. (2022) · Pharmaceuticals · doi:10.3390/ph15040475 · Cited by 131
“placed SV2 proteins as the primary candidates [102].”
BackgroundBotulinum Neurotoxin D Uses Synaptic Vesicle Protein SV2 and Gangliosides as Receptors
Peng, L., Tepp, W. H., Johnson, E. A., & Dong, M. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002008 · Cited by 132
Craige, B., Salazar, G., & Faúndez, V. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-12-1239 · Cited by 131
Johnson, E. A., & Montecucco, C. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01511-4 · Cited by 149
Chakkalakal, J. V., Nishimune, H., Ruas, J. L., Spiegelman, B. M., & Sanes, J. R. (2010) · Development · doi:10.1242/dev.053348 · Cited by 134
Synaptic vesicle protein 2A: basic facts and role in synaptic function
Mendoza‐Torreblanca, J. G., Vanoye‐Carlo, A., Phillips‐Farfán, B. V., Carmona‐Aparicio, L., & Gómez‐Lira, G. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12360 · Cited by 124
Synaptic Vesicle Glycoprotein 2A: Features and Functions
Rossi, R., Arjmand, S., Bærentzen, S. L., Gjedde, A., & Landau, A. M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.864514 · Cited by 123
“A first study (Bajjalieh et al., 1992), based on the deduced SV2 sequence, revealed that SV2 proteins contain 12 transmembrane domains and their NH2-terminal amino acid sequence resembles a family of bacterial transporters, suggesting a possible role of SV2 proteins as transmembrane transporters.”
BackgroundSV2 Acts via Presynaptic Calcium to Regulate Neurotransmitter Release
Wan, Q.-F., Zhou, Z., Thakur, P., Vila, A., Sherry, D. M., Janz, R., & Heidelberger, R. (2010) · Neuron · doi:10.1016/j.neuron.2010.05.010 · Cited by 138
Sulfotransferases and sulfated oligosaccharides
Honke, K., & Taniguchi, N. (2002) · Medicinal Research Reviews · doi:10.1002/med.10020 · Cited by 145
Vogl, C., Mochida, S., Wolff, C., Whalley, B. J., & Stephens, G. J. (2012) · Molecular Pharmacology · doi:10.1124/mol.111.076687 · Cited by 132
Puzzling Out Synaptic Vesicle 2 Family Members Functions
Bartholome, O., Van den Ackerveken, P., Sánchez Gil, J., de la Brassinne Bonardeaux, O., Leprince, P., Franzen, R., & Rogister, B. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00148 · Cited by 107
The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease Relevance
Stout, K. A., Dunn, A. R., Hoffman, C., & Miller, G. W. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00351 · Cited by 112
Role of the Extracellular Matrix in Alzheimer’s Disease
Sun, Y., Xu, S., Jiang, M., Liu, X., Yang, L., Bai, Z., & Yang, Q. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.707466 · Cited by 131
The SV2 Protein of Synaptic Vesicles Is a Keratan Sulfate Proteoglycan
Scranton, T. W., Iwata, M., & Carlson, S. S. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03535.x · Cited by 107
MFS transportome of the human pathogenic yeast Candida albicans
Gaur, M., Puri, N., Manoharlal, R., Rai, V., Mukhopadhayay, G., Choudhury, D., & Prasad, R. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-579 · Cited by 115
Imaging of Synaptic Density in Neurodegenerative Disorders
Carson, R. E., Naganawa, M., Toyonaga, T., Koohsari, S., Yang, Y., Chen, M.-K., Matuskey, D., & Finnema, S. J. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.263201 · Cited by 104
Wood, M. D., & Gillard, M. R. (2016) · Epilepsia · doi:10.1111/epi.13638 · Cited by 107
Traffic of Botulinum Toxins A and E in Excitatory and Inhibitory Neurons
Verderio, C., Grumelli, C., Raiteri, L., Coco, S., Paluzzi, S., Caccin, P., Rossetto, O., Bonanno, G., Montecucco, C., & Matteoli, M. (2006) · Traffic · doi:10.1111/j.1600-0854.2006.00520.x · Cited by 98
Synaptic Vesicle Traffic: Rush Hour in the Nerve Terminal
Jahn, R., & Südhof, T. C. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03533.x · Cited by 95
Localization of SNARE proteins and secretory organelle proteins in astrocytes in vitro and in situ
Wilhelm, A., Volknandt, W., Langer, D. J., Nolte, C., Kettenmann, H., & Zimmermann, H. (2003) · Neuroscience Research · doi:10.1016/j.neures.2003.11.002 · Cited by 94
Janz, R., Hofmann, K., & Südhof, T. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-22-09269.1998 · Cited by 92
SV2B Regulates Synaptotagmin 1 by Direct Interaction
Lazzell, D. R., Belizaire, R., Thakur, P., Sherry, D. M., & Janz, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407502200 · Cited by 100
SV2A and SV2C contain a unique synaptotagmin-binding site
Schivell, A. E., Mochida, S., Kensel-Hammes, P., Custer, K. L., & Bajjalieh, S. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.12.011 · Cited by 102
Self-citationSynaptic Vesicle Protein 2, A New Neuroendocrine Cell Marker
Portela‐Gomes, G. M., Lukinius, A., & Grimelius, L. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64645-7 · Cited by 90
Entering neurons: botulinum toxins and synaptic vesicle recycling
Verderio, C., Rossetto, O., Grumelli, C., Frassoni, C., Montecucco, C., & Matteoli, M. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400796 · Cited by 90
Gross, S. D., Hoffman, D., Fisette, P. L., Baas, P. W., & Anderson, R. A. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.130.3.711 · Cited by 108
Molecular mechanisms of neurotransmitter release
Fon, E., & Edwards, R. (2001) · Muscle and Nerve · doi:10.1002/mus.1044 · Cited by 51
Herman, G. A., Bonzelius, F., Cieutat, A.-M., & Kelly, R. B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12750 · Cited by 85
Levetiracetam Reverses Synaptic Deficits Produced by Overexpression of SV2A
Nowack, A., Malarkey, E. B., Yao, J., Bleckert, A., Hill, J., & Bajjalieh, S. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029560 · Cited by 81
“Mammals have three SV2 genes that encode the isoforms SV2A, SV2B, and SV2C [16,17,18,19].”
BackgroundSelf-citationMitochondrial Complex 1, Sigma 1, and Synaptic Vesicle 2A in Early Drug‐Naive Parkinson's Disease
Wilson, H., Pagano, G., de Natale, E. R., Mansur, A., Caminiti, S. P., Polychronis, S., Middleton, L. T., Price, G. J., Schmidt, K. F., Gunn, R. N., et al. (2020) · Movement Disorders · doi:10.1002/mds.28064 · Cited by 88
Finnema, S. J., Toyonaga, T., Detyniecki, K., Chen, M., Dias, M., Wang, Q., Lin, S., Naganawa, M., Gallezot, J., Lu, Y., et al. (2020) · Epilepsia · doi:10.1111/epi.16653 · Cited by 78
Presynaptic Neurotoxins with Enzymatic Activities
Rossetto, O., & Montecucco, C. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-74805-2_6 · Cited by 87
Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets
Li, Y. C., & Kavalali, E. T. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013342 · Cited by 79
A rat brain cDNA encoding the neurotransmitter transporter with an unusual structure
Liu, Q., Mandiyan, S., López‐Corcuera, B., Nelson, H. R., & Nelson, N. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81145-p · Cited by 76
Madeo, M., Kovács, A., & Pearce, D. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.c114.584516 · Cited by 83
Feany, M. Β., Yee, A., Delvy, M. L., & Buckley, K. M. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.123.3.575 · Cited by 69
Phosphorylation of Synaptic Vesicle Protein 2 Modulates Binding to Synaptotagmin
Pyle, R. A., Schivell, A. E., Hidaka, H., & Bajjalieh, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000674200 · Cited by 84
Self-citationLevetiracetam: the first SV2A ligand for the treatment of epilepsy
Klitgaard, H., & Verdru, P. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.11.1537 · Cited by 75
Donovan, D. M., Vandenbergh, D. J., Perry, M. P., Bird, G. S., Ingersoll, R., Nanthakumar, E. J., & Uhl, G. R. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00018-n · Cited by 69
Two Feet on the Membrane: Uptake of Clostridial Neurotoxins
Rummel, A. (2016) · Current topics in microbiology and immunology · doi:10.1007/82_2016_48 · Cited by 71
Synaptic vesicular monoamine transporter expression: distribution and pharmacologic profile
González, A. M., Walther, D. M., Pazos, Á., & Uhl, G. R. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90050-7 · Cited by 74
Finnema, S. J., Rossano, S., Naganawa, M., Henry, S., Gao, H., Pracitto, R., Maguire, R. P., Mercier, J., Kervyn, S., Nicolas, J., et al. (2019) · Epilepsia · doi:10.1111/epi.14701 · Cited by 65
The synaptic vesicle and its targets
Volknandt, W. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00408-w · Cited by 67
Kaempf, N., Kochlamazashvili, G., Puchkov, D., Maritzen, T., Bajjalieh, S. M., Kononenko, N. L., & Haucke, V. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501627112 · Cited by 63
Self-citationLi, S., Cai, Z., Zhang, W., Holden, D., Lin, S.-F., Finnema, S. J., Shirali, A., Ropchan, J., Carre, S., Mercier, J., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04357-w · Cited by 59
Pharmacology of Neurotransmitter Transport into Secretory Vesicles
Chaudhry, F. A., Boulland, J., Jenstad, M., Bredahl, M. K. L., & Edwards, R. H. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-74805-2_4 · Cited by 75
The synaptic vesicle protein synaptotagmin promotes formation of filopodia in fibroblasts
Feany, M. Β., & Buckley, K. M. (1993) · Nature · doi:10.1038/364537a0 · Cited by 63
SV2A and SV2C are not vesicular Ca2+ transporters but control glucose-evoked granule recruitment
Iezzi, M., Theander, S. S., Janz, R., Loze, C., & Wollheim, C. B. (2005) · Journal of Cell Science · doi:10.1242/jcs.02658 · Cited by 67
Brivaracetam: a novel antiepileptic drug for focal-onset seizures
Stephen, L. J., & Brodie, M. J. (2017) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285617742081 · Cited by 59
Herrmann, C. H., Volknandt, W., Wittich, B., Kellner, R., & Zimmermann, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13908 · Cited by 57
Synaptic vesicle protein 2: A multi-faceted regulator of secretion
Ciruelas, K., Marcotulli, D., & Bajjalieh, S. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.02.003 · Cited by 64
Self-citationSynaptic vesicle docking and fusion
Bajjalieh, S. (1999) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(99)80047-6 · Cited by 74
Self-citationMorgans, C. W., Kensel-Hammes, P., Hurley, J. B., Burton, K. A., Idzerda, R. L., McKnight, G. S., & Bajjalieh, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005230 · Cited by 64
Self-citationMercier, J., Provins, L., & Valade, A. (2017) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2017.11.003 · Cited by 59
Dardou, D., Dassesse, D., Cuvelier, L., Deprez, T., Ryck, M. D., & Schiffmann, S. N. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.063 · Cited by 63
PET Imaging for Early Detection of Alzheimer’s Disease
Bao, W., Jia, H., Finnema, S. J., Cai, Z., Carson, R. E., & Huang, Y. H. (2017) · PET Clinics · doi:10.1016/j.cpet.2017.03.001 · Cited by 59
Cai, Z., Li, S., Zhang, W., Pracitto, R., Wu, X., Baum, E. J., Finnema, S. J., Holden, D., Toyonaga, T., Lin, S.-F., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00618 · Cited by 58
Son, Y., Scranton, T. W., Sunderland, W. J., Baek, S. J., Miner, J. H., Sanes, J. R., & Carlson, S. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.451 · Cited by 52
Winkler, H. J. S. (1997) · Neurochemical Research · doi:10.1023/a:1022410506476 · Cited by 52
Sesack, S. R., & Snyder, C. L. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00087-y · Cited by 53
Expression of SV2 isoforms during rodent brain development
Crèvecœur, J., Foerch, P., Doupagne, M., Thielen, C., Vandenplas, C., Moonen, G., Deprez, M., & Rogister, B. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-87 · Cited by 57
Metadata
- Authors
- Bajjalieh, S. M., Peterson, K., Shinghal, R., & Scheller, R. H.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Science
- Published
- 1992-08-28
- Volume
- 257
- Issue
- 5074
- Pages
- 1271-1273
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1991772365
- Cited by
- 256
- References
- 25
- Citations by year
- 2026: 3 · 2025: 13 · 2024: 14 · 2023: 9 · 2022: 11 · 2021: 8 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 11 · 2016: 7 · 2015: 9 · 2014: 8 · 2013: 6 · 2012: 6
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
- Keywords
- synaptic vesicle protein 2, SV2, synaptic vesicles, membrane glycoproteins, transmembrane domain, bacterial transporters, sugar transporters, citrate transporter, drug transporters, membrane topology
- MeSH terms
- Amino Acid Sequence, Animals, Bacterial Proteins, Brain, Carrier Proteins, DNA, Electrophoresis, Polyacrylamide Gel, Fungal Proteins, Membrane Glycoproteins, Molecular Sequence Data, Nerve Tissue Proteins, Sequence Homology, Nucleic Acid, Transfection, Polymerase Chain Reaction, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.